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Message from the Assistant Secretary for Mental Health and Substance Use
As the first U.S. Department of Health and Human Services Assistant Secretary for Mental Health and Substance 
Use at the Substance Abuse and Mental Health Services Administration (SAMHSA), I am pleased to present this 
new resource: Preventing the Use of Marijuana: Focus on Women and Pregnancy. In response to the charge of 
the 21st Century Cures Act to disseminate information on evidence-based practices and service delivery models, 
the National Mental Health and Substance Use Policy Lab has developed the Evidence-Based Resource Guide 
Series focused on the prevention and treatment of substance use disorders and mental illnesses. With this guide, 
SAMHSA’s goal is to inform women and their health care providers of the potential effects of marijuana use, 
especially during pregnancy and the postpartum period.
According to the National Survey on Drug Use and Health (NSDUH), an estimated 53.2 million people used 
illicit drugs in the past year among those who are 12 and older. The most commonly used illicit drug in the past 
year was marijuana, which was used by 43.5 million people. In 2017, NSDUH showed that pregnant women were 
using substances in greater number, including significant increases in daily or nearly daily marijuana use. In the 
2018 NSDUH data, the news is more encouraging, as there was a significant decline in illicit drug use, including 
marijuana, by pregnant women. However, NSDUH showed daily use of marijuana by women who are not 
pregnant continued to increase.1
Preventing the Use of Marijuana: Focus on Women and Pregnancy addresses the established health risks 
of marijuana use to pregnant women and their children, as well as the expanding evidence base on other 
potential harms of use during pregnancy. I encourage you to use this guide to be informed of the adverse health 
consequences and potential effects of marijuana use, and to promote healthy decision-making among pregnant and 
postpartum women.
Elinore F. McCance-Katz, M.D., Ph.D.
Assistant Secretary for Mental Health and Substance Use
U.S. Department of Health and Human Services
MESSAGE FROM THE ASSISTANT SECRETARY  
FOR MENTAL HEALTH AND SUBSTANCE USE,  
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
1.  Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Key substance use and 
mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. 
Rockville, MD: Center for Behavioral Health Statistics and Quality, SAMHSA. 
Reference List
iv Preventing the Use of Marijuana: Focus on Women and Pregnancy
1
Preventing the Use of Marijuana: Focus on Women and Pregnancy 
Foreword
F O R E W O R D
Evidence-Based Resource Guide  
Series Overview
The Substance Abuse and Mental Health Services 
Administration (SAMHSA), and specifically, the 
National Mental Health and Substance Use Policy 
Laboratory, is pleased to fulfill the charge of the 21st 
Century Cures Act and disseminate information on 
evidence-based practices and service delivery models 
to prevent substance misuse and help individuals with 
substance use disorders (SUD), serious mental illnesses 
(SMI), and serious emotional disturbances (SED) get 
the treatment and support that they need.
Individuals in treatment and recovery vary in many 
ways. They face different mental and substance use 
disorders, may have co-occurring disorders, live in 
diverse parts of the country, and face a variety of 
socio-economic factors that help or hinder recovery. 
All these factors bring complexities to evaluating the 
effectiveness of services, treatments, and supports for 
the prevention and treatment of mental and substance 
use disorders. 
Despite variations, substantial evidence is available 
to understand the types of services, treatments, and 
supports that prevent and reduce substance use, lessen 
mental illness symptoms, and improve individuals’ 
quality of life. Communities are eager to take advantage 
of what has been learned to help individuals in need. 
The Evidence-Based Resource Guide Series is a 
comprehensive and modular set of resources intended 
to support healthcare providers, health care system 
administrators, and community members to meet 
the needs of individuals at risk for, experiencing, 
or recovering from substance use disorder and 
mental illness.
With this Resource Guide, SAMHSA’s goal is to 
inform women of the potential effects of marijuana 
use, especially during pregnancy and during the 
postpartum period, and to promote healthy decision-
making among this population. This guide examines 
the scientific literature on the risk factors for and 
adverse health consequences of marijuana use during 
pregnancy. It examines emerging and best practices to 
prevent or reduce such use. The guide also identifies 
key components of peer-reviewed models and 
discusses the challenges and strategies involved in 
implementing prevention programs.
Each guide in this series was developed through input 
from a technical expert panel representing the federal, 
state, and non-governmental sectors. Panels included 
accomplished scientists, service providers, community 
administrators, and federal and state policy makers. 
The expert panel members for this guide provided 
input based on their knowledge of health care systems, 
implementation of evidence-based practices, provision 
of services, and policies that foster change.
One Piece of a 
Multipronged Approach
Research shows that implementing evidence-based 
practices requires a comprehensive, multipronged 
approach. This guide is one piece of an overall 
approach to implement and sustain change. Users 
are encouraged to review the SAMHSA website for 
additional tools and technical assistance opportunities. 
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Focus of the Guide
Currently, there is no evidence on 
individual programs for the prevention 
of marijuana use among pregnant 
and postpartum women, and there 
is a need to address this research 
gap. This guide draws from evidence-
based practices and strategies for 
the prevention of substance use 
issues (e.g., alcohol, tobacco). 
Elements from these evidence-
based approaches may apply to 
marijuana use prevention, and may 
help clinicians and community-
based providers address the risks 
associated with the use of marijuana 
by pregnant and postpartum women.
There is a misperception of safety 
associated with marijuana use. Some 
women report strong beliefs about 
using “natural remedies” such as 
marijuana to address pregnancy-
related symptoms such as nausea 
and anxiety.
Before clinicians and community-
based prevention providers can 
communicate about the adverse 
health consequences that may be 
associated with marijuana use before, 
during, and after pregnancy, it is 
helpful to understand the existing 
evidence around the effects of 
marijuana exposure on fetal and 
infant outcomes.
Content of the Guide
Each guide contains a foreword and five chapters. The chapters are 
modular, and do not need to be read in chronological order.   
FW  Evidence-Based Resource Guide  
Series Overview
 Introduction to the series. 
1  Issue Brief 
 Overview of the issue of marijuana use among pregnant and 
postpartum women.  
2  What Research Tells Us 
 Review of evidence-based prevention practices, policies, and 
programs for addressing marijuana use among pregnant and 
postpartum women.
3  Examples of Effective Prevention 
Programs 
 Highlights from a sample of programs that use evidence-
based practices to prevent substance use by pregnant and 
postpartum women.
4  Implementing Evidence-Based 
Marijuana Use Prevention Practices 
for Pregnant and Postpartum Women
 Practical information to consider when implementing 
a marijuana use prevention program for pregnant and 
postpartum women.
5  Marijuana Use Prevention Resources 
for Implementation, Quality 
Improvement, and Evaluation 
of Programs 
 Resources for implementing evidence-based prevention 
practices and programs, maintaining high-quality prevention 
efforts, and monitoring outcomes.
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C H A P T E R
National estimates show that between 3 and 7 percent 
of pregnant women report using marijuana while 
pregnant.1,2 In 2018, there was a significant decline 
in illicit drug use by pregnant women. The decrease 
in marijuana use among pregnant women between 
2017 and 2018 (7.1 to 4.7 percent) contributed to 
this overall decline.2 A study of self-reported and 
biochemically tested marijuana use among pregnant 
women in California found that marijuana use during 
pregnancy was more common among younger women, 
with rates as high as 22 percent of pregnant adolescents 
and 19 percent of pregnant young adults (ages 19–24) 
screening positive for marijuana use.3
To assist clinicians and others in raising awareness 
of the known and potential harms of marijuana use 
during pregnancy, this guide focuses on the growing 
body of evidence related to maternal marijuana use. 
The evidence from population-based data on potential 
harms to newborns is mixed. Some studies rely on self-
reported data, which can underestimate the proportion 
of women who are using marijuana and skew study 
findings. Other factors, such as concurrent substance 
use, stress, socioeconomic status, and others, can 
influence the baby’s health.
Despite these limitations, evidence is mounting to show 
that babies born to mothers who report marijuana use 
are more likely to be preterm and underweight.4,5,6,7
Further, there is concern that marijuana is transferred 
through breast milk to the child.8,9 The primary 
psychoactive ingredient in marijuana, delta-9-
tetrahydrocannabinol (THC), has been found in breast 
milk for up to six days after maternal marijuana use.9 
Marijuana may cause problems with a newborn’s 
brain development and may result in hyperactivity, 
poor function, and other consequences.10 While further 
research is needed to establish whether there are 
adverse effects on infant development, the American 
Academy of Pediatrics states that breastfeeding is 
contraindicated in women using illicit drugs.11
Evidence suggests that women’s concerns about 
how substances will affect the developing fetus can 
motivate them to reduce or abstain from substances 
(e.g., alcohol, tobacco, and illicit drugs) during 
pregnancy.12,13 However, relapse tends to rise 
dramatically from 6 to 12 months following birth 
among women who abstain from marijuana use 
during pregnancy.13 The postpartum period, from 
birth through approximately 12 months after birth, 
corresponds to a critical developmental period for 
infants.
This chapter provides an overview of marijuana use 
among pregnant and postpartum women, as well as 
the adverse health consequences for mothers and their 
babies that may be associated with marijuana use both 
during and after pregnancy.
ISSUE BRIEF
Preventing the Use of Marijuana: 
Focus on Women and Pregnancy
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Key Definitions 
For this guide, the word “marijuana” is most often 
used to align with the general public’s understanding 
of the term.5  
Marijuana: Refers to the cannabis plant or 
derivative products that contain more than 0.3 
percent of the chemical compound delta-9-
tetrahydrocannabinol (THC), the main psychoactive 
component of marijuana responsible for the plant’s 
intoxicating effects.4
Cannabis Use Disorder: A persisting pattern 
of cannabis use that results in clinically significant 
functional impairment in two or more domains 
(e.g., school, work, social and recreational activities, 
interpersonal relationships), within a 12-month period. 
Cannabis use disorder can be classified as mild, 
moderate, or severe.15
Cannabinoids: A group of chemical compounds 
found in cannabis. Among the more than 100 types of 
cannabinoids are delta-9-tetrahydrocannabinol (THC) 
and cannabidiol (CBD).14
Cannabidiol (CBD): Cannabidiol is a component 
of the cannabis plant that does not produce a high. 
Research is exploring its therapeutic potential for 
pain, anxiety, inflammation, and substance use 
disorder. An FDA-approved medication, Epidiolex, 
which is used to treat certain seizure disorders in 
children, is made from plant-derived cannabidiol. CBD 
can be extracted from hemp plants (containing less 
than 0.3% THC) and is currently being marketed in 
many forms for mostly unproven indications.16 
Delta-9-Tetrahydrocannabinol (THC): 
The main psychoactive chemical in marijuana that 
is responsible for most of the intoxicating effects that 
people seek.17 Marijuana potency is determined by 
levels of THC, which vary widely among marijuana 
products.
Hemp: A strain of the Cannabis sativa plant that 
contains less than 0.3 percent THC. Many CBD 
products are derived from hemp, though they are not 
yet regulated by the FDA and may be of questionable 
quality and consistency.17
Substance Misuse: The initial use of substances 
before an individual develops a substance use 
disorder. This includes excessive use of a legal 
substance (e.g., alcohol), use of a prescription drug in a 
manner or dose other than as prescribed (e.g., opioids 
or stimulants), or any use of an illicit drug (e.g., heroin, 
cocaine, alcohol for minors).16,17,19
Medical Marijuana Use: The use of the whole, 
unprocessed marijuana plant or its basic extracts 
to treat symptoms of illness as recommended by 
an authorized practitioner in a state with a medical 
marijuana law. The FDA has not recognized or 
approved the marijuana plant as medicine. Continued 
research may lead to the development of more 
medications.16
Recreational Marijuana: Marijuana used for non-
medical purposes in jurisdictions that have legalized 
the purchase, possession, or consumption of cannabis 
for recreational use by an adult resident (21 or older). 
Child-Bearing Age: Ranges of ages during which 
a woman may become pregnant. Child-bearing age 
is typically defined as 15–44 or 15–49 years of age, 
although it is understood that girls younger than 15 
may become pregnant.20,21
Prevention Practice: A type of approach, 
technique, or strategy focused on prevention; for 
example, skill building with young adults or public 
service announcements regarding the harmful 
effects of marijuana use on the brain.22
Prevention Program: A set of predetermined, 
structured, and coordinated activities focused on 
prevention. A program can incorporate different 
practices. Guidance for implementing a specific 
prevention practice can be developed and distributed 
as a prevention program.22
Prevention Policies: Laws, regulations, 
procedures, administrative actions, incentives, 
or voluntary practices of governments and other 
institutions to promote improvements in health through 
evidence-based health interventions.23 
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Women Who Use Marijuana During Pregnancy
In 2018, 5.4 percent of women reported using illicit drugs during pregnancy.2 The drug most commonly used 
by pregnant women was marijuana.2
Notably, 34–60 percent of women who use marijuana continue use during pregnancy, with many believing that 
it is relatively safe to use during pregnancy and less expensive than tobacco.24 
Socioeconomic conditions and other risk factors such as those listed below may contribute to the same 
pregnancy outcomes otherwise attributed to marijuana. As a result, it is difficult to assess how much of an effect 
is specifically due to marijuana exposure. Compared to women who do not use marijuana during pregnancy, 
women who use marijuana during pregnancy:
Have limited 
or disrupted 
prenatal care24
Report having 
more stressors24,29
More often experience 
symptoms of mental 
health conditions28,29
Are more likely to use 
other drugs during 
pregnancy25,27,28
Are younger25,26,27,28
Have fewer previous 
pregnancies29
Are more likely to 
smoke 
cigarettes25,27,28,29
Are more likely 
to drink alcohol  
during pregnancy25,27,28,29
Experience nausea or vomiting 
during pregnancy. Women 
who experience nausea or 
vomiting during pregnancy are 
more likely to use cannabis 
compared to women who 
do not experience these 
symptoms.30,31
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Risk Factors for 
Marijuana Use
Research suggests that, in addition to personal factors, 
the social contexts in which people grow up, live, 
work, and play have a major influence on marijuana 
use and on the development of cannabis use disorder.24
While research on risk factors specific to marijuana 
use during pregnancy and the postpartum period 
is limited, evidence from broader young adult 
populations may be relevant for understanding and 
preventing substance misuse among pregnant and 
postpartum women.
Factors that can contribute to marijuana use in 
young adults include use by peers, family members, 
accessibility, and beliefs about whether or not 
marijuana is harmful. Additional factors contributing 
to cannabis use disorder in young adults also may be 
related to genetics, early trauma, or mental illness. 
Other influences driving use can include fluctuations 
in family structure, maternal substance use, poor 
academic performance, sexual or physical trauma, 
early initiation of smoking and alcohol consumption, 
and aggression and delinquency. Furthermore, risk 
factors such as early initiation, beliefs about risks and 
benefits, and access to or availability of marijuana 
are particularly relevant to pregnant and postpartum 
women.25,28, 32,33
Early Initiation of Marijuana Use 
Early onset of marijuana use is associated with a 
higher risk of developing cannabis use disorder.34
With regard to the development of cannabis use 
disorder, several different studies have found varying 
rates of cannabis use disorder among lifetime users, 
ranging from 9 percent to nearly 20 percent.35
Beliefs About Risks and 
Benefits of Marijuana 
Recent research points to changing perceptions about 
the harms of marijuana use. In 2018, one in four 12th 
graders reported that regular marijuana use poses 
a great risk (26.7 percent—which is less than half 
of what it was 20 years ago).36 In 2014, 33 percent 
of adults reported they believed regular marijuana 
use was harmful, compared to 50.4 percent in 2002 
reporting the same.37
Many women who use marijuana during pregnancy 
believe it is relatively safe.24 They use marijuana to 
treat and alleviate symptoms of nausea and vomiting 
during pregnancy. Research on the prevalence of 
marijuana use by pregnant women is limited. The 
prevalence of self-reported prenatal marijuana 
use is between 2 percent and 5 percent in most 
studies.28,38,39,80 A recent study of 279,457 pregnant 
women in northern California, however, has reported 
prenatal marijuana use among pregnant women 
with severe nausea and vomiting at 2.3 percent, but 
15 percent reported marijuana use for mild nausea 
and vomiting.40 Another study found that 96 percent 
of mothers who continued using marijuana during 
pregnancy reported that they did so to treat nausea.31
Availability of and Access to Marijuana 
There are multiple factors contributing to the 
perceived safety of marijuana use. As of June 25, 
2019, 14 states and territories have approved adult-
use marijuana/cannabis.41 A total of 34 states, the 
District of Columbia, Guam, Puerto Rico, and the U.S. 
Virgin Islands have approved comprehensive, publicly 
available medical marijuana/cannabis programs.41
One study found that states that allow medical 
marijuana have seen increases in marijuana treatment 
admissions among pregnant women.42 The study 
also found there was no association between 
medical marijuana laws and the number of treatment 
admissions among non-pregnant women.42
Studies have cited other factors—including 
uncertainty regarding adverse perinatal consequences, 
the perceived therapeutic effects of marijuana, and 
a lack of counseling from healthcare providers—as 
contributing to the perceived safety of marijuana use 
among pregnant women.28 
7
Preventing the Use of Marijuana: Focus on Women and Pregnancy 
Issue Brief
Further Contributing Risk Factors 
While research on the risk factors associated with marijuana use among pregnant and postpartum women is 
limited, studies of other substance (e.g., alcohol, tobacco) use during pregnancy may inform our understanding of 
the complex interplay between contributing factors. Examples include: 
Most people who use marijuana start between the ages of 15 and 18. Among the 11.3 million women ages 
12 and older who currently used marijuana in 2018, 3.4 million are between the ages of 18 and 25.2 Women are 
at highest risk for developing SUDs during their reproductive years, especially between the ages of 18 and 29.59
Individual Factors:
 ■ Personal history of alcohol and other 
substance misuse49,50,52,53,54
 ■ Personal history of inpatient treatment for 
substance or alcohol misuse and/or history 
of inpatient mental health treatment55
 ■ Post-traumatic stress disorder (often tied to 
adverse childhood experiences)56,57
 ■ Previous birth to a child adversely affected 
by substance use in utero47,58
Relationship and Genetic Factors:
 ■ Family history of alcohol and other 
substance misuse47,49
 ■ Physical, emotional, or sexual trauma as 
a child or adult45,50,51
 ■ Romantic partner who has a substance 
use disorder47,49
Community Factors:
 ■ Limited access to contraception and 
subsequent unplanned pregnancy45,46,47
 ■ Limited access to health care47,48
Societal Factors:
 ■ Policies that punish women for their 
substance use during pregnancy, including 
incarcerating women with SUDs, thereby 
limiting access to effective treatments43,44
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Potency and Content 
of Marijuana
Compared to the marijuana of 30 years ago, 
marijuana today is widely recognized as 
more potent.60 The potency of marijuana has 
consistently increased, with THC levels rising from 
approximately 4 percent in 1995 to about 17 percent 
in 2017.60,61 Much of the evidence on the risks and 
adverse outcomes of marijuana use comes from 
older studies using less potent forms of marijuana.
The FDA does not regulate marijuana. 
Consequently, marijuana may include contaminants 
such as pesticides and fungus; however, most states 
with legal cannabis have implemented regulations 
about pesticide use. The FDA recommends that 
pregnant and breastfeeding women talk with a 
health care provider about the potential adverse 
health effects of marijuana use.18
The FDA has approved one cannabis-derived 
(CBD) drug product for the treatment of two forms 
of severe epilepsy, and three THC-related drug 
products for the treatment of nausea and vomiting 
caused by cancer chemotherapy or weight loss 
and poor appetite in patients with AIDS. These 
medications are only available with a prescription 
from a licensed healthcare provider.18 
Harms Associated 
with Marijuana Use 
by Pregnant and 
Postpartum Women
Use of marijuana during and after pregnancy may 
pose risks to both mother and baby. Some research 
has documented effects of marijuana use during and 
after pregnancy, but much remains to be learned. 
Women should be aware of the realities and serious 
nature of these potential harms. Secondhand 
marijuana smoke contains THC and many of the 
toxic chemicals found in cigarette smoke. Exposure 
to secondhand marijuana smoke has been measured 
in nonsmokers.81,82 THC does accumulate in 
human breast milk, but its effect on infants remains 
unknown. Because an infant’s brain is continuing 
to develop, consuming THC in breast milk could 
affect brain development. Research is limited in 
this area, but it is a growing concern.
Birth Outcomes 
Women who frequently or regularly use marijuana 
during their pregnancy may be more likely to 
experience worse birth outcomes, including 
low birth weight babies and preterm delivery, 
compared to pregnant women who do not use 
marijuana. 
Studies show a clear association between 
prenatal marijuana use and low birth weight that 
is dependent on the mother’s level of use.5,25,63 
Preterm birth has been associated among women 
who used marijuana during pregnancy.83,84 Not 
all studies, however, have found this association 
between marijuana use and preterm birth, due to 
other confounding factors such as tobacco or other 
substance use.7,10,63 This is also likely a result of 
differing methodological approaches, including 
poor quantification of marijuana exposure and a 
lack of documentation for preterm birth in many 
studies. A systematic review and meta-analysis 
of maternal marijuana use and adverse neonatal 
outcomes found an association between heavy 
marijuana use and preterm birth.6  
Breastfeeding Outcomes  
Currently, there are insufficient data regarding the 
effects of marijuana use on breastfeeding infants. 
However, research suggests that chemicals from 
marijuana can be passed to infants through breast 
milk.64 THC is stored in fat and is released slowly 
over time, meaning an infant can still be exposed 
through breast milk even after a mother stops 
using marijuana.38,63,64,65,66
Additionally, studies show that women who 
smoke marijuana breastfeed for less time after 
birth.5,29,67 Breastfeeding is recommended by 
the American Academy of Pediatrics because 
it benefits a baby’s immune system, including 
antibodies, immune factors, enzymes, and white 
blood cells, all of which protect against diseases 
and infections even after the child has weaned.68
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The following major medical associations have 
advised against marijuana use during pregnancy:
 ■ The American College of 
Obstetricians and Gynecologists 
(ACOG) recommends women not use 
marijuana during pregnancy.24 
 ■ The American Academy of Pediatrics 
released its first official guidelines in 2018 
advising women who are pregnant or 
breastfeeding to avoid marijuana use because 
it is not safe for them or their children.25
 ■ The National Council of State Boards 
of Nursing states in its 2018 National 
Nursing Guidelines for Medical Marijuana 
that advanced practice registered nurses must 
consider the available scientific evidence 
around risks to particular groups 
of patients, including those of child-bearing 
age, pregnant women, and infants.62
Childhood Outcomes  
Research on this is limited (few longitudinal studies) 
and results are mixed because the women were also 
found to be using other substances (alcohol, tobacco). 
Also, data on these women were collected about 20 
years ago, when potency of marijuana was much lower 
than what is used today. The relationship between 
marijuana use during pregnancy and other childhood 
outcomes is unclear. There is some evidence to suggest 
that prenatal exposure is linked to children’s lower 
scores on tests of visual problem-solving, visual-motor 
coordination, and visual analysis.69,70,71,72 Prenatal 
marijuana exposure also is associated with decreased 
attention span and behavioral problems and is an 
independent predictor of marijuana use by 14 years 
of age.73,74,75 Effects of prenatal marijuana exposure 
on school performance remain unclear, with research 
having produced mixed results.5,76,77,78
Cannabidiol Products
CBD is marketed as a variety of products including 
drugs, food, dietary supplements, cosmetics, pet 
food, and other animal health products.
Other than Epidiolex® to treat rare, severe forms 
of epilepsy, the FDA has not approved any other 
CBD products.
Some CBD products are being marketed with 
unproven medical claims. Misleading and false 
claims associated with CBD products may lead 
consumers to put off seeking important medical 
care, such as proper diagnosis, treatment, and 
supportive care.
There are many unanswered questions about the 
science, safety, and quality of products containing 
CBD. No compelling evidence shows that the use 
of CBD oil during pregnancy (or at other times) 
is beneficial.
The FDA is working toward learning more about 
CBD, including its effects79:
 ■ On the body, such as toxicity to the liver, 
when someone ingests CBD regularly over a 
long period of time
 ■ From cumulative exposure across a broad 
range of consumer products
 ■ On special populations (e.g., the elderly, 
children, adolescents, pregnant and 
breastfeeding women) or types of animals 
(e.g., species, breed, or class)
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C H A P T E R
When examining program effectiveness, it is often 
difficult to isolate programs focused exclusively on 
preventing marijuana use. Women who use marijuana 
during pregnancy may also use other substances, such 
as tobacco, alcohol, or illicit drugs. Sometimes women 
who use marijuana during pregnancy also have 
experienced poverty, poor diet, interpersonal violence, 
or intergenerational trauma, any of which can 
influence pregnancy outcomes.1 Due to these factors, 
very few studies focus solely on preventing perinatal 
marijuana use. The best evidence available consists of 
prevention research on other substances.
The risk factors and issues surrounding other types of 
substance misuse during pregnancy may be similar to 
those surrounding marijuana use during pregnancy. 
This chapter focuses on a broader evidence base that 
includes studies of programs and practices designed 
to prevent substance misuse including, but not limited 
to, marijuana. Evidence-based programs are those 
that have demonstrated effectiveness in preventing or 
reducing substance misuse and its consequences.
Evidence of effectiveness falls along a continuum, 
from strong to weak. Strong evidence of a program or 
practice’s effectiveness comes from strong evaluation 
studies. Evidence is most compelling when studies 
of a practice or program are scientifically rigorous, 
numerous, and include testing among various 
populations and settings.2
2
Prevention of Unintended Pregnancy
In 2011, 45 percent of pregnancies in the 
United States were unintended.3 Women may 
continue to use substances without realizing 
they are pregnant. They may be unprepared 
or unable to stop using substances when they 
become pregnant.3
There is abundant evidence on the 
effectiveness of various contraception methods 
that are effective among women who frequently 
misuse substances or have a substance 
use disorder (SUD).4 Women who are using 
substances and do not wish to become 
pregnant should consider using one of these 
methods. The evidence for contraception 
methods is not included in this chapter.
WHAT RESEARCH TELLS US 
Effective Practices 
to Prevent Substance 
Use During Pregnancy
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Criteria for Assessing the Evidence
An expert panel developed the following criteria to guide the selection of evidence-based practices featured 
in this chapter. According to the expert panel, an evidence-based practice must: 
 ■ Be supported by evaluation studies that, at a minimum,
1. Employ a quasi-experimental research design with equivalent intervention and comparison groups;
2. Use methods to isolate the effects of the intervention and rule out alternative explanations for the 
outcomes found; and
3. Demonstrate prevention of, or reduction in, marijuana or other substance use prior to, during, or 
following pregnancy.
 ■ Include sound theory or logic that connects the evidence-based practice to the prevention of marijuana 
or other substance misuse (including alcohol and tobacco) prior to, during, or following pregnancy
 ■ Be incorporated into one or more programs that address risk or protective factors for marijuana or other 
substance misuse prior to, during, or following pregnancy
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 ■ Decreases in alcohol 
consumption during 
pregnancy11-15
 ■ Decreases in alcohol- 
exposed pregnancies11-15
 ■ Decreases in preterm 
labor rates16-20
 ■ Decreases in neonatal 
intensive care 
admissions16-20
 ■ Increases in infant 
birthweight16-20 
 ■ Decreases in number of 
infants exposed to 
maternal illicit drug use16-20 
 ■ Decreases in 
number of heavy 
drinking days during 
postpartum period21  
Screening, Brief Intervention, and Referral  
to Treatment (SBIRT)
Primary care and obstetrical providers often use screening, brief intervention, and referral to treatment (SBIRT) 
to identify alcohol and tobacco use among pregnant women. The U.S. Preventive Services Task Force recommends 
the use of SBIRT to address substance misuse, as do professional societies such as ACOG.5-7
Using a validated screening questionnaire, SBIRT helps identify women who misuse marijuana or have cannabis use 
disorder. Simply asking about alcohol and other substance use can also result in behavior change.8 When a healthcare 
provider recognizes that a woman is engaging in marijuana or other substance misuse, the woman receives brief 
counseling (5–10 minutes) from a trained prenatal provider.
During this brief intervention, prenatal providers often use motivational interviewing techniques that help women 
determine their interest in making life changes through individualized goal setting.9 Women whose screening results 
indicate that they have cannabis use disorder—and who have accepted they are in need of treatment—will receive a 
referral from the provider for treatment.
Since SBIRT studies that focus on marijuana use and pregnant women are limited, information from studies of other 
substances such as tobacco, alcohol, and illicit drugs contributes to the understanding of what works.10 Computer- 
based screening and brief intervention have had positive initial acceptability by women and are associated with 
healthy pregnancy outcomes.11, 12 
Outcomes Associated with SBIRT
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 ■ Reductions in maternal 
substance misuse prior to, 
during, and after pregnancy26-29
 ■ Increased engagement in 
treatment and prenatal care for 
women who use marijuana28
 ■ Improvements in infant 
outcomes and child welfare30
 ■ Improved attendance for 
postpartum appointments31
 ■ Decreased rates of breastfeeding 
discontinuation31
 ■ Increased use of effective postpartum 
contraception, including long-acting 
reversible contraception (LARC)31
Outcomes Associated with 
Integrated Clinics
Integrated Clinics 
for Pregnant and 
Parenting Women
Integrated clinics, sometimes referred to as integrated 
programs, are co-located health promotion and 
substance misuse prevention providers for pregnant 
and parenting women and their children. These clinics 
are “one-stop shops” that typically offer prenatal 
care, general primary care, counseling for mental and 
substance use disorders, services for parenting and 
child development, and other necessary supports (e.g., 
housing, transportation, legal aid, case management).
Such supports are designed to promote health equity 
by helping women who may be at increased risk 
for poor pregnant and postpartum outcomes—due, 
for example, to limited income and educational 
opportunities, mental illness, domestic violence, or 
sexual or other trauma—access the critical care that is 
readily available to other women who do not face such 
challenges.22, 23
Although the integrated clinic model has been around 
since the 1970s, the majority of states lack these 
clinics. Integrated clinics can function successfully 
with limited funding in existing primary care clinics 
via a person-centered medical home model.23
According to the Institute for Healthcare 
Improvement, the maternity medical home model 
adopts medical home principles to perinatal care and 
also incorporates several key elements that address 
risk factors and behaviors, such as substance misuse, 
that can affect a mother’s health and birth outcomes.
Key elements included in the maternity medical home 
model include:24
 ■ A standardized risk assessment to identify a 
woman’s needs
 ■ A focus on first-trimester entry into prenatal care
 ■ Care coordination to ensure that a woman 
receives all needed services during pregnancy
 ■ Standardized care pathways to target common 
risk factors for poor birth outcomes and ensure 
each woman receives all recommended care
 ■ Enhanced access such as expanded hours and 
improved ability to contact providers
 ■ Person-centered care, including shared decision 
making about key aspects of perinatal care (such 
as where and how labor and delivery take place)
The medical home model includes:25
 ■ A personal physician
 ■ A physician-directed medical practice
 ■ Whole-person orientation
 ■ Coordinated and integrated care
 ■ A quality and safety focus
 ■ Enhanced access to care
 ■ Payment that recognizes the value offered to 
individuals by the model
Evidence indicates that integrated clinics improve 
prenatal appointment attendance, birth outcomes, 
parenting, and overall maternal mental health.26-31
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Health Communication 
Campaigns to 
Change Behaviors
Health communication campaigns seek to 
promote change or produce outcomes among a 
certain population or the general public. Health 
communication campaigns can:32
 ■ Provide direct information to those who are 
expected to adopt a healthy behavior or change 
an unhealthy behavior
 ■ Use multiple communications methodologies 
such as social media, television, radio, and 
appointments with healthcare professionals and 
outreach workers
 ■ Influence the adoption of healthy behaviors by 
changing knowledge and beliefs about behaviors, 
perceived social norms, and actual skills and 
confidence in skills 
There is limited research on the effectiveness of 
communication campaigns to prevent or reduce 
marijuana use among pregnant or postpartum women. 
However, it is possible to extrapolate from evaluations 
of communication campaigns that focus on other 
substances and target the general population or other 
audience segments.
For example, health communication campaigns 
have been effective in changing beliefs about tobacco 
use, preventing the initiation of tobacco use, and 
promoting tobacco cessation.33 Campaigns have been 
especially effective in reducing tobacco use among 
youth. These campaigns use commercial marketing 
tactics, including branding of messages, images, and 
warning labels, to refute pro-substance influences and 
increase pro-health messages and influences. 
Successful health communication education 
campaigns require a great deal of thoughtful 
planning on the front end. A recent study reports 
that states using more aggressive negative messaging 
regarding alcohol use during pregnancy in such 
campaigns actually saw worse pregnancy outcomes 
and higher costs.34, 35
To be effective, key messages should provide 
accuracy and consistency without shaming or blaming 
women.36 Messaging that is more likely to be effective 
will target the reasons women use marijuana during 
pregnancy, explain the known and possible risks of 
marijuana use during pregnancy, and promote the use 
of medications known to be safe in pregnancy.
Social Norms
Social norms are implicit or explicit rules about which 
behaviors are acceptable in society. Social norms 
change is an opportunity to change behavior on a 
societal level.42 By changing public perception, public 
health campaigns can “de-normalize” risky behavior. 
Most work on social norms change has been done 
with tobacco, starting with the Surgeon General’s 
1964 report.43
Outcomes of campaigns implemented 
as part of comprehensive tobacco 
control programs:
 ■ Prevention of tobacco smoking 
initiation in youth37
 ■ Promotion of tobacco smoking 
cessation in adults37-39
 ■ Reduction in relapse rates 
among individuals who have 
quit smoking40
Campaigns that elicit negative 
emotions through graphic and personal 
portrayals of the health consequences 
of tobacco use can lead to:
 ■ Motivation for smokers to quit37-39
 ■ Reduction in tobacco use among 
youth and young adults33, 41
Outcomes Associated 
with Health Communication 
Campaigns
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Contingency 
Management for 
Reducing Use
Contingency management is one of the most effective 
approaches to treating SUDs. Typically implemented 
in clinical settings, contingency management relies 
on “operant conditioning,” or providing rewards to 
individuals based on their level of behavioral change. 
In the case of marijuana use, the behavioral change 
would be periods of abstinence.
When implementing contingency management, the 
clinician will:44, 45
1. Arrange for regular testing to ensure that the 
individual is abstaining from substance use.
2. Provide agreed-upon and tangible rewards, such 
as vouchers, when the individual abstains.
3. Withhold the reward or incentive from the 
individual when substance use is detected.
4. Assist the individual in establishing alternate and 
healthier activities to replace the rewards derived 
from substance use.
Many programs use this practice during pregnancy 
to promote healthy prenatal behavior in women, 
such as reducing or quitting substance misuse.46, 47 
Contingency management has proven effective for 
helping pregnant women quit smoking.48 It is also 
effective for helping women in general abstain from 
cocaine, tobacco, and heroin.47, 49, 50
A recent systematic review of evaluation research shows 
that incentives for tobacco smoking cessation may 
be especially effective for pregnant women.51 While 
no studies focus on the effectiveness of contingency 
management to prevent marijuana use in pregnancy, 
one study reveals the potential of the practice to decrease 
marijuana use for a set amount of time in young adults 
(ages 18–25 years) not seeking to discontinue long-term 
use.52 This study is particularly relevant, as 7.5 million 
women between the ages of 18 and 25 use marijuana 
and are in the child-bearing age range.
 ■ Be willing and able to engage 
in SUD treatment47
 ■ Be willing to quit or temporarily 
stop smoking tobacco products 
during pregnancy and the 
postpartum period48
 ■ Reduce use of illicit 
drugs such as cocaine 
and heroin47, 49, 50
Outcomes Associated with 
Contingency Management 
Pregnant and postpartum women who are 
introduced to contingency management are 
more likely to:
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Postpartum Home Visits 
by Health Professionals 
The postpartum period can be a risky time for women 
to relapse and engage in substance misuse. This is a 
time when women experience the loss of the social 
and medical support they received during their 
pregnancy. Approximately 1 in 9 women experience 
postpartum depression.53 Women face the challenges 
of caring for a helpless newborn while simultaneously 
struggling to heal their own bodies. These stressors 
may be risk factors for marijuana misuse.
Further, breastfeeding mothers are at risk for passing 
chemical components of marijuana to their infants.54 
Being under the effect of marijuana may impact child 
care duties. These factors can lead to infant neglect 
and harm.55
Several practices help women cope with challenges 
in the postpartum period. Of these, one of the most 
studied is home visitation. The Health Resources and 
Services Administration (HRSA) and other public 
and private organizations provide support for home 
visitation programs. Home visitation programs can 
include help from health, social service, and child 
development professionals. Families that elect to 
participate receive regular, planned home visits during 
which they learn family management and childcare 
strategies that are likely to improve family functioning 
and child health outcomes.
According to HRSA, home visits may include:
 ■ Supporting preventive health and 
prenatal practices
 ■ Advising mothers on how best to breastfeed 
and care for their babies
 ■ Helping parents understand child development 
milestones and behaviors
 ■ Promoting parents’ use of praise and other 
positive parenting techniques
 ■ Working with mothers to set goals for the future, 
such as continuing their education or finding 
employment and childcare solutions
 ■ Improvement in infant and 
child health56-61
 ■ Reduction in substance misuse 
among children as they grow 
into adolescence and young 
adulthood62-64
 ■ Reduction in child abuse 
and neglect65, 66
 ■ Improvement in child social 
and emotional development67, 68
 ■ Improvement in child school 
readiness67, 68
 ■ Improvement in maternal health56-61
 ■ Linkages and referrals to appropriate 
social supports and resources for 
the family69
 ■ Improvement in family economic 
self-sufficiency70
 ■ Increase in positive parenting 
practices67, 71
Outcomes Associated with 
Home Visiting Programs
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Policies to Prevent and 
Reduce Marijuana Use  
Concerns about the implementation of punitive 
strategies may deter women from seeking health care 
during and after pregnancy.72, 73 
The evidence shows that policies can prevent the 
initiation of substance misuse and reduce current 
adolescent use.74-78 Initiation of marijuana use in 
adolescence is a risk factor for marijuana use during 
pregnancy. Thus, preventing marijuana use among 
adolescents is one method for reducing marijuana use 
among pregnant women.
Much of the research concerning policies to reduce 
substance use in adolescent populations focuses on 
alcohol use. There is little research on the impact of 
marijuana policies. Implementation and evaluation 
of policies designed to prevent and reduce underage 
drinking and its associated consequences offer some 
guidance that may be applicable to preventing or 
reducing marijuana use during adolescence.
Lawmakers have developed, enacted, and applied 
policy strategies that target society- and community- 
level influences to reduce underage drinking and its 
associated consequences. These strategies include 
raising the minimum legal drinking age, setting a 
lower blood alcohol concentration (BAC) limit for 
young drivers, and limiting commercial and social 
access to alcohol.
ADS
$
Policy
Increase the price through excise 
taxes and other methods
Outcome  
Reductions in:
 ■ Underage consumption74-78
 ■ Consumption frequency74-78
 ■ Amount consumed74-78
 ■ Motor vehicle fatalities76, 79-81
 ■ Occurrences of driving while 
intoxicated76, 79-81
Policy
Provide deterrents to using or 
incentives for not using, such as 
driver’s license suspension 
following an offense or reducing 
the BAC limit for young people
Outcome  
Reductions in:
 ■ Minors in possession violations85, 86
 ■ Traffic deaths87, 88
Policy
Restrict use and sale of alcohol at youth 
and community events 
Outcome  
Reductions in:
 ■ Underage consumption82-84
 ■ Negative social and legal 
consequences of underage 
consumption82-84
Policy
Restrict advertising to minors
Outcome  
Reductions in:
 ■ Youth traffic fatalities89
 ■ Alcohol consumption90
 ■ Occurrences of binge drinking90
Outcomes Associated with Policies to Reduce Underage Drinking
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C H A P T E R
This chapter highlights six prevention programs 
designed to address and reduce substance misuse 
among pregnant and postpartum women. Each 
program uses one or more of the evidence-based 
practices described in Chapter 2. The Chapter 2 
practices featured include:
 ■ Screening, brief intervention, and referral 
to treatment (SBIRT) 
 ■ Integrated clinics for pregnant and 
parenting women 
 ■ Health communication campaigns to 
change behaviors
 ■ Contingency management for reducing 
marijuana use
 ■ Postpartum home visits by health professionals 
 ■ Policies to prevent and reduce marijuana use 
While there may be programs that focus on the 
prevention of marijuana use among pregnant or 
postpartum women, there is limited research or data 
available on the effectiveness of any such program. 
The best available data comes from programs that 
focus on preventing tobacco, alcohol, opioids, heroin, 
and other substance misuse among pregnant and 
postpartum women. Lessons from these successful 
programs may be applied to programming for 
marijuana use prevention. For example, while the 
CDC’s Tips From Former Smokers® (Tips®) campaign 
addresses tobacco use, its strategies focus on 
messaging that affect behaviors and, therefore, can be 
generalized to address marijuana use as well. 
Choosing Programs 
While there are additional effective programs that 
could have been featured in this chapter, the programs 
described below were considered to be well defined, 
promising, and representative of prevalent practice 
models, according to the technical panel of experts 
who provided input on this guide. These programs 
meet the evidence-based criteria and practices featured 
in Chapter 2. Each program has achieved positive 
outcomes for the prevention of substance misuse 
among pregnant or postpartum women.
Examples of Effective 
Prevention Programs  
3
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Overview of Programs Featured
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Evidence-Based 
Practice(s) 
Featured
SBIRT
Integrated Clinics
Health 
Communication 
Campaign
Contingency 
Management
Integrated 
Clinics
Postpartum 
Home Visits
Policies to Prevent 
and Reduce 
Marijuana 
Use 
Policies to 
Prevent and 
Reduce 
Marijuana 
Use 
Substance(s) Addressed
Alcohol
Tobacco
Illicit Drugs  
Tobacco Tobacco
Tobacco
Alcohol
Marijuana
Opiates
Methamphet-
amine
Illicit Drugs 
Alcohol Alcohol
Focus on 
Pregnancy    
Focus on
Postpartum Period  
Populations 
of Focus Pregnant Women
General 
Public 
Women of 
Child-Bearing 
Age
Pregnant 
Women
Pregnant 
Women
Postpartum 
Women
Qualifying 
Support 
Partner 
Pregnant and 
Postpartum 
Women with 
Substance 
Use Disorders
Family 
Members
Youth less 
than 21 
years of age
Youth less 
than 21 
years of age
Format of the Chapter 
For each of the six programs featured within this chapter, uniform headings present information such as key features, 
implementation strategies, populations of focus, outcomes, and more.  
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Key Features
 ■ The program’s co-location in a 
prenatal clinic ensures universal 
screening and consistent early 
identification of substance misuse. 
 ■ Licensed Early Start specialists 
provide assessment, information, 
and early intervention. 
 ■ The program incorporates prenatal 
provider education, consultation, and 
training to support effective program 
operation.
Evidence-Based Practice
SBIRT; integrated clinics
Preventing Substance Misuse 
Alcohol; tobacco; illicit drugs
Populations of Focus 
Women served in Kaiser Permanente 
prenatal care settings who use 
substances. Kaiser Permanente is 
a large not-for-profit health plan that 
serves 12.3 million members across the 
United States.
Kaiser Permanente  
Early Start
https://earlystart.kaiserpermanente.org
Program Description
Kaiser Permanente’s Early Start is a program to improve neonatal 
outcomes for babies of substance-using women who receive care 
at community-based outpatient obstetric clinics. The program 
integrates substance use prevention and treatment services with 
routine prenatal care and places Early Start specialists within the 
care team to provide counseling services on-site. 
Pregnant women at risk for using alcohol, tobacco, and/or 
misusing other substances during pregnancy receive immediate 
assessment, intervention, and ongoing case management services 
with their routine prenatal visits. Referrals to SUD treatment and 
other community support programs are available. Most women 
see the Early Start specialist only once, though women who need 
additional support can receive follow-up visits.
Opportunities
The Early Start Program provides pregnant women with a range 
of benefits to help them have a healthy pregnancy and a healthy 
baby, including:
 ■ Facilitating universal screening and early identification of 
pregnant women misusing substances
 ■ Integrating SUD services into routine prenatal care
 ■ Providing specialist counseling services on-site at the 
primary care clinic
Implementation Strategies
Staffing: In large clinic settings, staffing consists of one full-
time licensed Early Start specialist for every 1,800 births. In 
smaller community settings, the amount of staffing time needed 
could be prorated according to the number of annual births 
occurring at several clinics.
Cost: Kaiser’s Early Start implementation costs in northern 
California were $670,600 annually (including costs for 27.4 
full-time equivalent Early Start specialists). A cost-benefit 
analysis showed a net cost benefit averaging $5,946,741 per 
year, indicating that the benefits derived from implementing 
the program far outweighed the costs of 
implementing it.1  
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Outcomes
Mothers who 
participated in 
the program also 
experienced: 
 ■ Fewer preterm 
deliveries4,5
 ■ Fewer stillborn births4,5
 ■ Fewer placental 
abruptions4,5
 ■ Lower cost of maternal 
care, as compared to 
women with SUDs who 
did not participate in 
the program1
Babies born to mothers 
who participated in the 
program experienced:
 ■ Lower rates of assisted 
ventilation4,5
 ■ Healthier birth weights4,5
Of women who participated in the program, 69% did not engage in any illicit drug use during 
pregnancy or through delivery.2,3 
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Tips From Former Smokers® 
(Tips®) Campaign
https://www.cdc.gov/tobacco/campaign/tips/index.html
Program Description
The Centers for Disease Control and Prevention (CDC) 
launched the Tips From Former Smokers® (Tips®) campaign 
in March 2012. The Tips campaign features profiles of real 
people who are living with the serious long-term health effects 
of smoking and exposure to secondhand smoke. Over the 
course of this campaign, Tips has featured compelling stories 
from former smokers about their smoking-related diseases 
and disabilities, and the toll these conditions have had on their 
lives. 
Tips advertisements focus on the health issues that are caused 
by, associated with, or made worse by smoking or secondhand 
smoke exposure. One of these issues is preterm birth.
Key messages in the Tips campaign include:
 ■ Smoking causes immediate damage to your body, which 
can lead to long-term serious health problems.
 ■ For every person who dies because of smoking, at least 
30 people live with a serious smoking-related illness.
 ■ Now is the time to quit smoking
Opportunities
Through the Tips campaign website, the CDC provides 
free resources for those seeking to quit or help others quit 
smoking. Examples of these materials include:  
 ■ Social media images
 ■ FAQs
 ■ Expert talking points
 ■ A pocket card for talking with smokers who want to quit
These materials are customized for use 
by specific audiences, including faith-
based organizations, healthcare providers, 
organizations serving military members 
and veterans, and organizations serving 
residents in public housing. 
Key Features6
 ■ Media placement for this 
campaign reaches three-quarters 
of U.S. adults.6
 ■ Tips advertisements have appeared 
on television in all U.S. media 
markets through commercial 
advertising time on cable television 
networks.6
 ■ The campaign had a ubiquitous 
national buy and a local “buy up” 
strategy in which the campaign 
was broadcast through smaller local 
television channels in media markets 
with a high prevalence of cigarette 
smoking.6
Evidence-Based Practice
Health communication campaign
Preventing Substance Misuse 
Tobacco
Populations of Focus 
The general public, women of child-
bearing age, and pregnant women. 
Secondary audiences include family 
members, healthcare providers, and faith 
communities.
It is important to note that the evidence 
on health effects of marijuana use is 
still emerging. A campaign centered 
on health effects should be careful to 
focus on those aspects of health risks of 
marijuana that are well-established (e.g., 
low birth weight, preterm birth, transfer 
of THC to baby in breast milk, cognitive 
effects on offspring). 
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Implementation Strategies 
The Tips campaign is a national initiative that is well-funded and designed by an advertising firm. Essential lessons 
for implementation of smaller-scale communication campaigns include:
Planning: Consider key messages, define target audiences, and focus on reach and channels for getting the 
message out. 
Stakeholder engagement: Engage key stakeholders—including healthcare providers, opinion leaders, and 
other influential people—in getting the message out. 
Graphic and personal portrayals of negative health consequences: Demonstrate the real harms 
that are associated with substance use in ways that are likely to elicit an emotional response.
Outcomes 
It is estimated that 80% of US cigarette smokers saw at 
least one Tips message in 2012. Audiences averaged 23 views 
over a 12-week period.6
As a result of the Tips campaign:6-10
Non-smokers reported increased 
conversations with family or friends 
about the dangers of smoking. 
Non-smokers reported 
greater knowledge of 
smoking-related diseases.
Smokers who saw ads reported 
greater intentions to quit within 
30 days and 6 months. 
Smokers who saw the ads 
multiple times reported even 
greater intentions to quit.
Exposure to the ads was 
associated with increased 
smoking cessation among 
pregnant women.11
1.64 million smokers 
made a quit attempt.
100,000 smokers 
quit for good.
Approximately 17,000 
premature deaths from 
smoking were averted.
179,000 years of 
healthy life were gained.
The Tips campaign website also offers clinical tools for providers to help them counsel individuals on how to quit 
smoking (https://www.cdc.gov/tobacco/campaign/tips/partners/health/index.html).
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BABY & ME – 
Tobacco Free Program™
http://babyandmetobaccofree.org
Program Description
The BABY & ME – Tobacco Free Program™ is an evidence-
based smoking cessation program created to reduce the impact 
of tobacco use on pregnant and postpartum women and their 
children. The program’s primary goal is to reduce infant 
mortality and morbidity by helping women stop or reduce 
smoking while pregnant and after childbirth. The program 
also helps family members who live with pregnant and 
postpartum women avoid tobacco use. 
During pregnancy, the program engages women and family 
members in prenatal information sessions. Those who stop 
smoking while attending the sessions are provided with 
incentives, such as diaper vouchers. Women are encouraged 
to return to the program after their child is born. Women who 
continue to abstain from tobacco receive incentives up to 12 
months postpartum.
Opportunities
The BABY & ME – Tobacco Free Program helps pregnant 
and postpartum women, as well as their families, by: 
 ■ Ensuring program facilitators are trained in motivational 
interviewing techniques and are focused on the stages of 
change
 ■ Developing individualized tobacco cessation strategies in 
partnership with each woman, tailored to her situation
 ■ Incentivizing regular program participation and progress 
through vouchers
 ■ Providing ongoing monitoring of smoking behaviors 
during both pregnancy and the postpartum period
Key Features
 ■ Women, and family members who 
live with the pregnant woman, 
are asked to attend four prenatal 
sessions where they receive 
information, resources, and other 
supports to help them quit smoking.
 ■ After approximately two sessions, 
women and/or family members 
are tested for tobacco use using a 
carbon monoxide (CO) monitor. 
 ■ Those who are tobacco-free are 
rewarded with vouchers for diaper 
and baby wipe purchases. 
 ■ After childbirth, women can return 
monthly to the program to continue 
CO testing. Women receive diaper 
and baby wipe vouchers for each 
month they remain tobacco-free.
Evidence-Based Practice
Contingency management
Preventing Substance Misuse 
Tobacco
Populations of Focus 
Pregnant women who use tobacco or 
who recently quit. In some programs, 
qualifying support partners or family 
members may also enroll. BABY & ME – 
Tobacco Free programs are available in 
more than 20 states. 
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Implementation Strategies 
Staffing: Agencies, stakeholders, and facilitators must complete a one-day training. During the training, 
participants are given all information and materials necessary to implement and enroll women into the program. 
Additional technical assistance is available through the national BABY & ME – Tobacco Free program office.
Funding sources: Some states and health insurance providers reimburse sites offering the program. Additional 
funding may be identified and available through partnerships with departments of public health, community-based 
health centers, physician offices, and other health and human service agencies. 
Outcomes
Women who attend at least 3 
prenatal sessions significantly 
reduce the average number of 
cigarettes smoked daily compared 
to those who attend fewer sessions 
or are nonparticipants.13
Participants of the program 
who attend at least three 
sessions have reduced rates 
of low-birthweight babies 
compared to nonparticipants.13
Implementation of the 
program in Colorado 
resulted in a 72% success 
rate in terms of smoking 
reduction and cessation at 
6 months postpartum.15
The program estimates that it has 
saved $1.9 million in healthcare 
costs for newborn care.14 
Women who participate in the BABY & ME – Tobacco 
Free Program have better maternal and infant outcomes.12-14 
$
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University of New Mexico 
Milagro Program
https://hsc.unm.edu/health/patient-care/behavioral-health/
addiction-recovery/prenatal-program.html
Program Description
The University of New Mexico (UNM) Milagro Program is 
for pregnant women with an alcohol and substance use history 
or who are currently using substances. The program seeks to 
prevent and treat substance misuse during and after pregnancy. 
Women involved in the program receive their prenatal care 
from UNM Health System providers in the system’s family 
medicine clinics. Additionally, a team of providers, including 
counseling, case management, and other professionals, works 
together to ensure the well-being of the mother. The team 
works with the pregnant woman and her family before and 
after the baby is born.
The program started in 1989 and is one of the oldest 
integrated prenatal programs that addresses SUDs. The 
program screens for many substances, including tobacco, 
alcohol, marijuana, opioids, and other drugs. Due to the 
program’s integrated approach to health care, it can address 
the needs of women through inpatient stays, outpatient clinic 
visits, in the community, and even at home. Services include 
high-risk prenatal care, SUD treatment and counseling, case 
management, parenting classes, domestic violence support 
groups, trauma counseling, anger management counseling, 
and relapse prevention planning.
Opportunities
Care is provided through an integrated network of inpatient 
and outpatient healthcare and social service providers. 
Integrated provider teams develop trauma-informed care 
and treatment plans to address prenatal care, childbirth and 
postpartum care, substance use prevention and treatment, and 
care for the baby. Individualized treatment plans may include:
 ■ In-hospital care for stabilization with methadone or 
buprenorphine
 ■ Services offered in English and Spanish
 ■ Treatment for spouses and partners
Key Features
 ■ Treatment plans are customized to 
fit the needs of the expectant mother 
and include prevention strategies and 
supports.
 ■ Treatment teams made up of relevant 
healthcare professionals holistically 
address each woman’s needs.
 ■ Care is integrated with UNM hospitals 
and allows the provider team to follow 
women and their newborns during 
inpatient hospital stays. 
 ■ Medication-assisted treatment (MAT) 
is available for women with an 
opioid use disorder (OUD), with all 
maternity care providers prescribing 
buprenorphine.
Evidence-Based Practices
Integrated clinics; postpartum home visits
Preventing Substance Misuse 
Tobacco; alcohol; marijuana; opioids; 
methamphetamine; other illicit drugs
Populations of Focus 
Pregnant women and their families 
with SUDs throughout New Mexico 
and surrounding areas, with most 
participants residing in the 
Albuquerque metropolitan area.  
More than 90 percent of the women in 
the program have an OUD and are on 
MAT. Many, however, have polysubstance 
misuse, most commonly reporting 
methamphetamine and marijuana as 
secondary substances.
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 ■ Coordination with affiliated residential facility, an alternative to incarceration
 ■ Collaboration and postpartum transition of care to a program for the entire family which provides trauma-
informed care including case management; newborn, pediatric, and developmental care for babies; and ongoing 
substance use care including MAT for parents for up to three years after delivery
Implementation Strategies
Staffing: Integrated provider teams include case managers, care coordinators, community health workers, nurses, 
substance misuse counselors, family medicine residents, and staff physicians.
Costs: Much of the program’s cost can be covered by health insurance. In some cases, state policies dictate 
whether case management services are reimbursed.
Funding sources: The Milagro program was originally funded by a SAMHSA grant. The program has sustained 
operations through a combination of state and local funding, combined with medical billing. 
Outcomes 
The Milagro program offers impressive benefits to the women it serves:16,17
72%
of pregnant 
women prescribed 
buprenorphine 
continued on the 
medication until 
delivery.
70%
of women who start 
MAT for OUDs 
have negative urine 
drug screenings, 
meaning they are 
no longer engaging 
in opioid use.
74%
of the women will 
be breastfeeding 
their infants upon 
hospital discharge 
following delivery. 
39%
of the women will be 
breastfeeding their 
infants at 2 months 
after delivery.
43
Preventing the Use of Marijuana: Focus on Women and Pregnancy 
Examples of Effective Prevention Programs 
Minimum Age of Purchase, 
Sale, and Server Laws
https://alcoholpolicy.niaaa.nih.gov
Program Description
Evidence shows that policies limiting minors’ access to 
alcohol can reduce alcohol initiation and consumption among 
adolescents, both of which have been linked to problem 
drinking in adulthood.24 Similarly, early initiation of marijuana 
use is linked to marijuana use during pregnancy.19-23
Minimum age of alcohol purchase, seller, and server laws are a 
suite of alcohol control policies that stipulate the minimum age 
for alcohol transactions. 
1. Minimum age of purchase laws prohibit minors 
from buying or attempting to buy alcoholic beverages. 
2. Minimum age of seller laws specify a minimum 
age for employees who sell alcoholic beverages in 
off-premises establishments (e.g., liquor, grocery, and 
convenience stores).
3. Minimum age of server laws specify a minimum 
age for employees who serve or dispense alcoholic 
beverages in on-premises establishments (e.g., bars and 
restaurants).
Legal parameters of these policies—including age restrictions, 
compliance checks, vendor/retailor sanctions, and more—vary by state. 
State-level information on key components of purchase, seller, and 
server laws, as well as the use of false identification, can be found at 
the Alcohol Policy Information System website: https://alcoholpolicy.
niaaa.nih.gov.
Opportunities
Laws regulating the minimum age of alcohol purchasers, 
sellers, and servers are designed to change drinking behavior 
among young people, many of whom are women of child-
bearing age. The same would be true of similar policies 
limiting minors’ access to marijuana (in states where 
recreational marijuana use has been legalized).
Key Features
 ■ State-specific policies have been 
designed to reduce underage 
drinking by limiting minors’ access to 
alcohol. 
 ■ Policies can regulate the minimum 
age of alcohol purchase, seller, and 
server laws. 
 ■ Policies also can control pro-
alcohol messaging through alcohol 
advertising restrictions.
Evidence-Based Practice
Policies to prevent and reduce  
marijuana use
Preventing Substance Misuse 
Alcohol
Populations of Focus 
Youth less than 21 years of age
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Youth marijuana use prevention champions and 
stakeholders can collaborate with community leaders 
to pinpoint ways to strengthen existing laws in states 
where recreational marijuana use has been legalized. 
For example, if the state does not already do so, 
champions and stakeholders can consider enhancing 
current efforts to prevent minors from using false 
identification (ID) to purchase marijuana by: 
 ■ Prohibiting the production, sale, distribution, 
possession, and use of false IDs for attempted 
marijuana purchase
 ■ Implementing universal ID checks of all 
marijuana customers
 ■ Requiring two or more different ID cards at point 
of purchase
 ■ Issuing driver licenses and state ID cards that can 
be electronically scanned24
 ■ Allowing retailers to confiscate apparently false 
IDs for law enforcement inspection25
 ■ Using holographs and colors to make the 
manufacture of false IDs more difficult26
Implementation Strategies
Collaboration: Foster collaboration between 
prevention champions/stakeholders and community 
leaders and their staff to help draft revisions to, and 
shepherd, new legislation. 
State-level support: Utilize media advocacy 
strategies to increase awareness and garner state-level 
support for policy revisions. 
Enhanced enforcement activities: 
Enhance enforcement activities (through collaboration 
between stakeholders and community leaders) 
related to minimum age of transaction laws, such 
as compliance checks or compliance surveys and 
responsible server training. 
Informational opportunities: Provide 
informational opportunities (other than direct mail) to 
retailers and the general public about policy changes, 
compliance requirements, enforcement methods, and 
penalties as needed to enhance deterrence effects.27
Additional guidance: Learn more about 
implementation strategies for underage alcohol control 
policies, and consider how they could be translated 
into underage marijuana prevention policies, through 
the following resources: 
 ■ Report to Congress on the Prevention and 
Reduction of Underage Drinking
 ■ State Performance and Best Practices for the 
Prevention and Reduction of Underage Drinking
 ■ Effectiveness of Sanctions and Law 
Enforcement Practices Targeted at 
Underage Drinking Not Involving 
Operation of a Motor Vehicle
 ■ Policies to Reduce Commercial Access 
to Alcohol
 ■ Regulatory Strategies for Preventing 
Youth Access to Alcohol: Best Practices
Outcomes
Underage drinking policies lower drinking rates 
among underage youth:
 ■ Compared to geographic areas with fewer 
underage drinking policies, areas with four 
or more underage laws (e.g., laws requiring a 
minimum age for servers and sellers, fake ID 
restrictions, laws on attempts to purchase or 
consume, laws requiring the posting of warning 
signs in alcohol outlets) have:28
 - Lower alcohol use rates
 - Lower rates of drinking in the past 30 days
 - Lower binge-drinking rates
 ■ States with stricter laws regarding the use of 
false IDs to purchase alcohol have:29 
 - Lower rates of alcohol-related traffic 
fatalities involving underage drinkers 
 ■ States with laws establishing 21 as the minimum 
age to sell alcohol have:28
 - Lower alcohol use
 - Lower binge-drinking rates
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Advertising Restrictions
http://www.camy.org/_docs/research-to-practice/promotion/
legal-resources/state-ad-laws/CAMY_State_Alcohol_Ads_
Report_2012.pdf
Program Description
Evidence shows that policies restricting exposure to pro-
alcohol advertising can reduce alcohol initiation and 
consumption among adolescents, both of which have been 
linked to problem drinking in adulthood.18 Similarly, early 
initiation of marijuana use is linked to marijuana use during 
pregnancy.19-23
Advertising restrictions include any policies that limit 
advertising of alcoholic beverages, particularly advertisements 
that expose young people to pro-alcohol messages. Such 
policies can include regulations on electronic media (e.g., 
radio, television, internet), print media (e.g., magazines and 
newspapers), outdoor billboards, and signs. 
Opportunities
Policy restrictions on alcohol advertising to minors can be 
applied to prevention efforts around marijuana use in women 
of child-bearing age, many of whom are minors and would be 
included in the primary audience of any such efforts. 
Several lessons from alcohol advertising policy restrictions 
could benefit similar restrictions around marijuana (in states 
where its recreational use has been legalized) including: 
 ■ Establishing a distance threshold, including all types of 
marijuana advertising, and displaying the international 
“child” symbol on any billboard in the exclusionary zone
 ■ Prohibiting advertising in student publications of 
all college campuses located in the state that have a 
substantial readership less than 21 years old, providing 
exceptions to protect advertisers’ ability to reach those of 
legal age
 ■ Considering a multifaceted approach by combining 
advertising restrictions with other underage marijuana use 
prevention efforts or interventions to maximize overall 
effectiveness (in terms of alcohol use, examples of such 
interventions include keg registration, mandatory 
responsible beverage service training, and enforcement of 
bar capacity regulations)32
Key Features
 ■ State-level advertising regulations 
have been designed to reduce 
underage drinking through provisions 
that prohibit false or misleading 
alcohol advertising, advertising 
that targets underage youth, and 
advertising where youth are likely 
to be present, including on college 
campuses.30
 ■ Other kinds of restrictions (e.g., 
local ordinance or voluntarily 
implemented business, event, or 
organizational policies) have been 
designed to minimize youth exposure 
to alcohol promotion and advertising 
in public venues, such as on public 
transportation and at community 
events.31
Evidence-Based Practice
Policies to prevent and reduce 
marijuana use
Preventing Substance Misuse 
Alcohol
Populations of Focus 
Youth less than 21 years of age
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Implementation Strategies
Lawmaking body: Most states use their Alcoholic Beverage Control (ABC) agency to administer advertising 
regulations, since alcohol distributors and retailers must obtain licenses from this agency to do business in a state. 
The ABC agency has the authority to enact regulations, investigate infractions, and impose sanctions as needed.30
Experienced team members: Individuals or organizations with expertise in supporting the adoption, 
implementation, and enforcement of new regulations (or modifications to existing regulations) are essential to 
implementing alcohol advertising restrictions. 
Prevention champions and stakeholders: 
Stakeholders committed to preventing marijuana use among minors (including pregnant women) are key to mobilizing 
and building support for this type of policy within a community. Stakeholders can include law enforcement; religious, 
educational, or parent groups; town councils; and local advertising or marketing firms. 
Additional guidance: Learn more about implementation strategies for underage alcohol advertising regulations, and 
consider how they could be translated into underage marijuana advertising regulations, through the following resources: 
 ■ Alcohol Marketing and Advertising: A Report to Congress
 ■ Center on Alcohol Marketing and Youth
 ■ Out of Home Advertising Association of America: Code of Industry Principles
Outcomes
Underage alcohol advertising 
regulations lower drinking 
rates among underage 
youth. Both partial bans and 
complete bans on alcohol 
advertising have been 
associated with reduced 
alcohol consumption in 
20 countries.33,34
Alcohol advertising regulations 
have been associated with:36
 ■ Lower rates of adolescent 
alcohol consumption
 ■ Reduced frequency 
of adolescent alcohol 
consumption
 ■ Older age of first 
alcohol use
States with laws 
prohibiting alcohol 
advertising targeting 
minors have fewer youth 
alcohol-related, single-
vehicle, driver traffic 
fatalities compared 
to states without this 
regulation.35
Youth who lived in 
markets with less alcohol 
advertising were found to:37
 ■ Drink less
 ■ Increase their drinking 
more modestly until 
their early 20s 
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C H A P T E R
Introduction
Prevention programs are more likely to be successful 
if organizations implement them thoughtfully. One 
comprehensive guide that can help organizations 
plan, implement, and evaluate prevention programs 
and practices—including those focused on preventing 
marijuana use among pregnant and postpartum 
women—is SAMHSA’s Strategic Prevention 
Framework (SPF). 
SAMHSA developed the SPF to offer prevention 
planners a comprehensive approach to understanding 
and addressing the substance misuse and related 
behavioral health problems facing their states and 
communities. Visit SAMHSA’s website to learn 
more about the SPF (https://www.samhsa.gov/sites/
default/files/20190620-samhsa-strategic-prevention-
framework-guide.pdf).
Another helpful model for implementation is Getting 
to Outcomes® (GTO).1 The 10-step GTO approach 
leads to increased capacity for prevention programs 
and better performance. This approach has been 
the centerpiece of a number of federal prevention 
resources.1-3
Implementing Evidence-Based Substance 
Use Prevention Practices for Pregnant and 
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Getting to Outcomes Model 
Steps 1–6 of the GTO model focus on planning for implementation. Steps 7–10 focus on evaluation and quality 
improvement of prevention efforts. The model is meant to create a feedback loop whereby lessons learned from 
implementing prevention practices can inform future prevention initiatives. 
1.  
FOCUS: 
Choose which problem 
and related risk factors 
to focus on.
4.  
ADAPT: 
Modify the programs 
or best practices to fit 
your needs.
6.  
PLAN: 
Make a plan for getting 
started—determine  
who, what, where, 
when, and how.
5.  
RESOURCES: 
Assess capacity 
(staffing, finances) 
to implement the 
program.
2.  
TARGET: 
Identify goals, target 
population, and 
desired outcomes.
7.  
MONITOR: 
Track planning and 
implementation.
3.  
ADOPT: 
Find existing programs 
and best practices 
worth implementing.
8.  
EVALUATE: 
Determine outcomes 
that can be used 
to determine if the 
program is meeting 
goals.
Prevention Programs 
for Marijuana Use 
Among Pregnant and 
Postpartum Women
9.  
IMPROVE: 
Make a plan for 
continuous quality 
improvement.
10.  
SUSTAIN: 
Consider how to keep 
the program going if it 
is successful.
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Key Considerations for 
Implementing Prevention 
Practices and Programs 
To maximize the impact of your intervention when 
implementing prevention programs, it is important to 
not only select the right program or practice, but also:  
1. Maintain that program’s core elements, and
2. Balance core elements with program adaptation 
so that it meets the needs of the people you serve 
and your capacity to implement.
Maintaining Core Program 
Elements  
Once a program or practice is selected for 
implementation, planners need to identify which 
components of the intervention they will incorporate. 
Core intervention elements are the key ingredients 
to achieving good outcomes. Understanding and 
adhering to the principles underlying each core 
element may allow for flexibility in form without 
sacrificing the function associated with the element. 
Knowing the core program elements may allow for 
more efficient and cost-effective implementation 
and lead to decisions about what can be adapted to 
suit local conditions. Core program elements may be 
best defined after several attempted applications of a 
program or practice, not just the original one.
Adapting the Program
Remaining faithful to the original design of an 
evidence-based program or practice, while addressing 
the unique needs and characteristics of the target 
audience, requires balancing the maintenance of core 
elements with adaptation. When planners change a 
program, they risk compromising outcomes. However, 
implementing a program that requires some adaptation 
may be more efficient and cost-effective than 
designing a program from scratch. 
Some guidelines organizations can consider when 
balancing fidelity and adaptation include: 
 ■ Retaining core elements
 ■ Building capacity before changing the program
 ■ Adding rather than subtracting elements 
(adapting with care)
 ■ Getting help from developers or other experts  
(if adapting)
Staff Selection
Beyond academic qualifications or 
experience factors, certain practitioner 
characteristics are difficult to teach in 
training sessions and are therefore a crucial 
part of the selection criteria. The staff 
selection process also can represent an 
intersection with larger system variables. 
Ongoing Consultation and 
Coaching 
Most of the skills practitioners need 
can be introduced in training, but really 
are learned on the job with the help 
of a consultant or coach. Training and 
coaching are the principal ways in which 
behavior change is brought about for 
selected staff in the beginning stages and 
throughout the process of implementing 
evidence-based practices and programs. 
Staff and Program 
Evaluation 
Staff evaluation is designed to assess 
the use and outcomes of the skills 
that are reflected in the staff selection 
criteria, taught in training, and reinforced 
and expanded in consultation and 
coaching processes. Assessments 
of practitioner performance and 
measures of fidelity also provide 
useful feedback to managers and 
implementers regarding the progress 
of implementation efforts and the 
usefulness of training and coaching. 
System Interventions 
System interventions are strategies 
that work with external systems to 
ensure availability of the financial, 
organizational, and human resources 
required to support the work of 
practitioners. 
Pre-Service and In-Service 
Training
Trainings are efficient ways to impart 
knowledge of background information, 
theory, philosophy, and values. They 
also help to introduce the components 
and rationales of key practices and 
provide opportunities to practice new 
skills and receive feedback in a safe 
environment.
Facilitative Administrative  
Support 
Facilitative administrative support provides 
leadership and makes use of a range of data 
inputs to inform decision making, support 
overall processes, and keep staff organized 
and focused on the desired outcomes.
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Facilitating Factors of Implementation
The goal of implementation is to have practitioners base their interactions with women who are pregnant or 
postpartum on research findings around evidence-based practices and programs. Facilitating factors help accomplish 
this task and include the following.4 
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Challenge  
Public Misperception About the 
Safety of Marijuana Use 
 Actions 
  Provide scientific and accurate information.
  Position information in strategic places 
where women will see it. 
  Use technology and social media.
There is widespread public misperception about 
marijuana use and its adverse health effects on 
the body and brain.8, 9 Pregnant and postpartum 
women may read inaccurate information about 
marijuana use, potentially believing that it is a 
“natural” or “safe” cure for pregnancy symptoms 
such as nausea and anxiety.10 
It is important to expose pregnant and 
postpartum women to accurate information 
about the effects of marijuana use. Efforts to 
inform women about marijuana use should use 
or borrow from the largely successful efforts to 
inform women about the effects of tobacco use 
and alcohol consumption on maternal health, 
fetal health, and child development. Messages 
should be clear, direct, and simple, such as those 
in the Tips From Former Smokers® campaign 
(see Chapter 3 for more information). 
Targeted placement of informational materials 
in doctors’ offices, health centers, salons, and 
baby supply stores can underscore key messages. 
Consider where pregnant and postpartum 
women, as well as their families and friends, will 
be exposed to messaging, and target prevention 
efforts accordingly. Find the right prevention 
vehicles for disseminating information. These 
could include social media, text messaging, or 
educational apps for electronic devices. 
!Challenges to 
Implementing Marijuana 
Use Prevention Programs 
Among Pregnant and 
Postpartum Women
Implementing programs to prevent marijuana use 
among pregnant and postpartum women can be 
challenging. Despite the possible benefits of such 
programs, barriers to their implementation exist 
that must be addressed. Primary barriers include 
discrimination and stigma that keep women from 
disclosing their substance use; lack of clinician time 
and training; and evolving changes in local, state, 
or federal policies around the legality and use of 
marijuana.5-7
Key to overcoming these challenges is informing 
stakeholders about the potential adverse health 
consequences of marijuana use for the pregnant 
woman, fetus, and postpartum mother and child. It is 
important to communicate the availability of effective 
prevention models to reduce such adverse health 
consequences. Information should be shared with 
expectant mothers and their families, health system 
administrators and practitioners, and other popular 
opinion leaders.
What follows are some of the primary challenges most 
commonly faced by community leaders who seek to 
implement prevention programs focused on marijuana 
use by pregnant and postpartum women. For each 
challenge, there are practical actions recommended. 
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Challenge  
Failure of Many Protocols and 
Procedures in Healthcare Settings 
to Accommodate Prevention 
Programs
 Actions 
  Integrate regular screening for marijuana use 
into routine workflows.
  Recognize that there are many prevention 
options such as in-office interventions, 
home visits, partnerships with community 
organizations, and referral services.
  Become educated about health insurance 
and other payment strategies for funding 
prevention efforts.
   
Challenge  
Reluctance Among Pregnant 
Women to Admit to Marijuana Use 
 Actions 
  Educate staff around how to discuss 
marijuana use in a non-judgmental manner.
  Train staff on motivational interviewing (see 
Chapter 2).11
  Educate staff and health care system 
leadership regarding confidentiality  
issues such as the Health Insurance 
Portability and Accountability Act (HIPAA)  
and 42 CFR Part 2 regulations.*
The laws and regulations of almost all local, 
state, and federal jurisdictions contain language 
relating to marijuana use. In many communities, 
enforcement of drug laws can result in a denial 
of medical or income benefits.12 While some 
states are legalizing marijuana for recreational 
purposes, recreational marijuana use is illegal in 
most states.13 Knowing about these laws, some 
healthcare providers may view people who use 
marijuana through a criminal lens. They also 
may see them based on stereotypes of those who 
have a history of marijuana use.
Although many laws governing marijuana intend 
to prevent its use to enhance maternal and fetal 
health, their implementation may indirectly 
limit access to care. Pregnant and postpartum 
women who use marijuana, for example, may 
be reluctant to disclose their use due to fear of 
punishment or a belief that healthcare providers 
will treat them like criminals.5,13
Pregnant and postpartum women who use 
marijuana deserve the same quality of care 
as anyone else. For some, marijuana use may 
be a manifestation of a larger substance use 
disorder (SUD). Efforts should be made to 
prioritize marijuana use as a health problem 
rather than a criminal act in states that have not 
decriminalized recreational use. 
Information about the risks and harms of 
marijuana use should be presented in a factual, 
respectful, and non-judgmental manner to gain 
women’s trust. Pregnant and postpartum women 
will be more likely to seek help if they think they 
will be treated with respect. 
Part of addressing discrimination and prejudice 
is using person-first language.12 For example, 
providers should refer to “a pregnant woman 
who uses marijuana,” not a “marijuana-using 
pregnant woman.” 
Finally, providers should be fully educated about 
privacy and confidentiality statutes such as 
HIPAA and 42 CFR Part 2 (the federal laws and 
regulations protecting the privacy of people’s 
records relating to SUDs). Misunderstanding of 
these statutes can lead some providers to avoid 
discussing marijuana use in treatment settings.
*It is important to note that unless the program in which the woman is enrolled for prenatal/post-partum care 
where the proposed intervention(s) will occur meets the definition of a 42 CFR program (i.e., a program that 
holds itself out as providing treatment for substance use disorders), it is not governed by the 42 CFR privacy 
regulations. Rather, HIPAA regulations would apply to the health record.
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Health systems have a unique role to play in 
helping prevent marijuana use by pregnant 
and postpartum women. However, health care 
professionals often have much to cover in 
the limited time they have to spend with each 
individual. 
Often, changes to regular office visit protocols 
to include prevention counseling need 
administrative approval. Further, many staff 
lack training on how to implement prevention 
approaches as part of their clinical practice. 
Systems change would require training not only 
for doctors, nurses, and physician assistants, but 
also for receptionists, office staff, technicians, 
and nursing assistants who have frequent 
contact with pregnant and postpartum women. 
Communities may not have adequate 
referral resources for women who are having 
difficulties stopping their marijuana use or 
have other SUDs. There is also a lack of 
insurance coverage and other payment 
provisions for marijuana use-related counseling 
or treatment. It is important for health systems 
to be familiar with reimbursement strategies 
that enable payment for the provision of 
services needed to counsel or treat pregnant 
women at risk of using marijuana. 
Laws regulating marijuana use vary widely from 
state to state. Many states are in the process of 
drafting new laws that will affect marijuana 
commerce and personal use. This volatile policy 
context complicates prevention efforts because 
problems, risk factors, and strategies are likely to 
vary by state.
In this area, there is much to learn from alcohol 
and tobacco use, especially laws affecting 
minors. With regard to tobacco and alcohol, the 
public is much more comfortable regulating the 
behavior of minors than adults. Some policy 
evaluations have shown that strategies designed 
to regulate underage use of tobacco and alcohol 
(namely, by limiting access and availability) can 
be quite successful in delaying or preventing 
the initiation of use, which is important because 
early initiation during adolescence is linked to 
problematic use in adulthood.14,15
Similarly, policies and practices designed to 
reduce the harms associated with tobacco 
and alcohol use also have been successful. 
Such strategies have focused on identifying 
pregnant women who are using alcohol and 
tobacco, counseling them on the harms of use to 
themselves and the fetus, and helping them set 
and meet goals to quit using.
 
   
Challenge  
Wide Variance of Regulations 
Affecting Marijuana Use by State
 Actions 
  Adapt tobacco and alcohol use policy 
solutions that address initiation to 
marijuana use.
  Focus on preventing harms associated with 
marijuana use during the postpartum period.
  Expand Medicaid for postpartum care to 
ensure that women get the help they need to 
prevent relapse.
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C H A P T E R
This chapter lists tools and resources to support 
marijuana use prevention among pregnant women, 
postpartum women, and women of child-bearing 
age. These resources can be used to guide practice 
and improve public health programming. For each 
resource, a website is provided. The resources are 
organized into the following categories:
1. Clinical Guidelines
2. Implementation Planning
3. Quality Improvement
4. Evaluation 
Clinical Guidelines 
The guidelines covered within this section address 
both marijuana and tobacco use, as a high percentage 
of women who use marijuana also use tobacco 
products (see Chapter 2). The prevention efforts that 
have proven successful for helping pregnant and 
postpartum women avoid or quit tobacco use may also 
be applied to marijuana use prevention efforts. This is 
helpful, considering that very few clinical guidelines 
focus exclusively on marijuana use among women of 
child-bearing age.
 ■ Marijuana Use During Pregnancy 
and Breastfeeding: Implications for 
Neonatal and Childhood Outcomes  
This clinical report from the American Academy 
of Pediatrics provides data on the current rates of 
marijuana use among pregnant and breastfeeding 
women. The report presents information on the 
effects of marijuana on fetal development and later 
neurodevelopmental and behavioral outcomes. The 
report also addresses implications for education 
and policy. https://pediatrics.aappublications.org/
content/142/3/e20181889
Marijuana Use 
Prevention Resources 
for Implementation, 
Quality Improvement, and 
Evaluation of Programs 
5
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 ■ Academy of Breastfeeding Medicine 
Clinical Protocol #21: Guidelines for 
Breastfeeding and Substance Use or 
Substance Use Disorder, Revised 2015  
A central goal of the Academy of Breastfeeding 
Medicine is the development of clinical protocols 
for managing common medical problems that may 
influence breastfeeding success. The purpose of 
Clinical Protocol #21 is to provide literature-based 
guidelines for addressing the needs of women 
with a history of past or current substance use or a 
substance use disorder (SUD) who are considering 
breastfeeding. https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4378642
 ■ American College of Obstetricians 
and Gynecologists (ACOG) Committee 
Opinion Number 722: Marijuana Use 
During Pregnancy and Lactation  
This resource focuses on marijuana use during 
pregnancy and lactation. It is an educational 
resource to aid clinicians who provide obstetric and 
gynecological care. https://www.acog.org/Clinical-
Guidance-and-Publications/Committee-Opinions/
Committee-on-Obstetric-Practice/Marijuana-Use-
During-Pregnancy-and-Lactation
 ■ ACOG Tobacco and Nicotine Cessation 
Toolkit   
Developed by ACOG’s Wellness Work Group on 
Tobacco Cessation, this toolkit assists obstetrician- 
gynecologists and women’s healthcare providers  
in addressing the issue of tobacco and nicotine 
cessation. The toolkit presents screening tools for 
tobacco and nicotine use (including e-cigarette 
use) and resources to help women stop use. https://
www.acog.org/About-ACOG/ACOG-Departments/
Toolkits-for-Health-Care-Providers/Tobacco-and-
Nicotine-Cessation-Toolkit
 ■ Guidelines for Identification and 
Management of Substance Use and 
Substance Use Disorders in Pregnancy    
These guidelines from the World Health 
Organization contain recommendations for 
identifying and addressing the needs of pregnant 
and postpartum women who use illicit substances 
or are diagnosed with SUDs. https://www.who.
int/substance_abuse/publications/pregnancy_
guidelines/en
 ■ Marijuana Pregnancy & Breastfeeding 
Guidance: For Colorado Health Care 
Providers Prenatal Visits     
This evidence-based clinical resource document for 
healthcare providers offers language for talking to 
women about marijuana use during pregnancy and 
while breastfeeding. https://www.colorado.gov/
pacific/sites/default/files/MJ_RMEP_Pregnancy-
Breastfeeding-Clinical-Guidelines.pdf
 ■ Pediatric Exposure Prevention: Clinical 
Guidance for Colorado Health Care 
Providers      
This resource provides information for healthcare 
providers to talk with parents of children and youth 
about marijuana use and exposure.  https://www.
colorado.gov/pacific/sites/default/files/MJ_RMEP_
Pediatric-Parents-Clinical-Guidelines.pdf
 ■ Tobacco Smoking Cessation in Adults, 
Including Pregnant Women: Behavioral 
and Pharmacotherapy Interventions       
This resource includes recommendations made by 
the U.S Preventive Services Task Force regarding 
smoking cessation and pregnant women. https://
www.uspreventiveservicestaskforce.org/Page/
Document/RecommendationStatementFinal/
tobacco-use-in-adults-and-pregnant-women-
counseling-and-interventions1
63
Preventing the Use of Marijuana: Focus on Women and Pregnancy 
Marijuana Use Prevention Resources for Implementation, Quality Improvement, and Evaluation of Programs 
Data Resources and Survey Tools 
When planning to implement a prevention program, it is important to consider how your population and community 
compare with others. The following data resources provide national indicators that offer a viable way to compare 
community indicators to national ones. The national survey tools are also good resources that can be administered at 
the community level.
 ■ National Survey on Drug Use and Health 
(NSDUH)  
This annual survey interviews people across the 
country to provide national and state-level estimates 
of tobacco, alcohol, and illicit drug use and mental 
health. The SAMHSA survey provides data on 
levels and patterns of substance use, tracks usage 
trends, assesses consequences, and identifies groups 
at high risk for substance use. https://www.samhsa.
gov/data/data-we-collect/nsduh-national-survey-
drug-use-and-health
 ■ Behavioral Risk Factor Surveillance 
System (BRFSS)   
This CDC survey system collects state data about 
U.S. residents regarding their health-related risk 
behaviors, chronic health conditions, and use of 
preventive services. https://www.cdc.gov/brfss/
index.html
 ■ Drug Abuse Warning Network (DAWN)    
DAWN is SAMHSA’s nationally representative 
public health surveillance system that continuously 
monitors drug-related visits to hospital emergency 
departments. DAWN monitors trends in drug 
misuse, identifies the emergence of new substances 
and drug combinations, assesses health hazards 
associated with drug misuse, and estimates the 
impact of drug misuse on the nation’s health 
care system. https://www.datafiles.samhsa.gov/
study-series/drug-abuse-warning-network-dawn-
nid13516
 ■ Pregnancy Risk Assessment 
Monitoring System (PRAMS) 
PRAMS collects state-specific, population-based 
data on maternal attitudes and experiences before, 
during, and shortly after pregnancy. Data can be 
used to identify groups of women and infants at 
high risk for health problems, to monitor changes in 
health status, and to measure progress toward goals 
in improving the health of mothers and infants. 
https://www.cdc.gov/prams/index.htm
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Implementation Planning 
Developing and implementing prevention programs 
involves several steps, including the formulation 
of a plan that considers effective strategies and 
practices, as well as access points to reach women, 
their families, and their communities. Resources 
within this section provide guidance for the selection 
of appropriate prevention practices. Also included 
are materials that can be adapted from prevention 
programs focused on tobacco, alcohol, and other 
substance use prevention.   
Screening Tools
 ■ The Cannabis Use Disorder 
Identification Test—Revised (CUDIT-R)       
This is a brief, eight-item screening measure to 
identify hazardous cannabis use that could require 
intervention. https://bpac.org.nz/BPJ/2010/June/
docs/addiction_CUDIT-R.pdf
 ■ Patient-Reported Outcomes 
Measurement Information System 
(PROMIS)®        
PROMIS® includes more than 300 measures of 
physical, mental, and social health among the 
general population and individuals living with 
chronic conditions. PROMIS developed self-
report measures for adults around functions, 
symptoms, behaviors, and feelings. http://www.
healthmeasures.net/explore-measurement-
systems/promis/intro-to-promis
Professional Education Resources
 ■ Is Marijuana Safe to Use While Pregnant 
or Breastfeeding?         
This federal resource from the National Institute 
on Drug Abuse provides recommendations for 
healthcare providers regarding how to advise 
pregnant and breastfeeding women who use 
marijuana. https://www.drugabuse.gov/marijuana-
safe-to-use-while-pregnant-or-breastfeeding
 ■ Emory University School of Medicine, 
Center for Maternal Substance Abuse 
and Child Development        
This site offers fact sheets, resource guides, and 
articles on marijuana and pregnancy. http://www.
emory.edu/msacd/Individuals and Families/
Information.html
 ■ Marijuana and Your Baby         
This fact sheet provides information about 
marijuana, pregnancy, and breastfeeding from 
the Colorado Department of Public Health and 
Environment. https://www.colorado.gov/pacific/
sites/default/files/MJ_RMEP_Factsheet-Pregnancy-
Breastfeeding.pdf
 ■ MotherToBaby          
This website provides evidence-based information 
on the safety of medications and other exposures 
during pregnancy and while breastfeeding. The 
site includes fact sheets on various drugs and 
prescription medications and their impact on 
pregnancy. https://mothertobaby.org
 ■ Weed to Know for Baby and You  
This public campaign, operated by the Spokane 
Regional Health District, provides facts about 
the harm associated with marijuana use during 
pregnancy, breastfeeding, and caring for a baby. 
https://srhd.org/weed-to-know-baby-you
Program Development and 
Community-Based Services 
 ■ American Academy of Pediatrics, 
Substance Use and Prevention: 
Information on Marijuana 
This website provides resources on the latest 
policies, education, and news regarding marijuana. 
https://www.aap.org/en-us/advocacy-and-policy/
aap-health-initiatives/Substance-Use-and-
Prevention/Pages/marijuana.aspx
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 ■ The Guide to Community Preventive 
Services (The Community Guide)  
The Community Guide is a collection of evidence-
based findings of the Community Preventive Services 
Task Force. It is intended to help in the selection of 
interventions to improve health and prevent disease 
in states, communities, community organizations, 
businesses, healthcare organizations, and schools. 
https://www.thecommunityguide.org
 ■ Prevention Technology Transfer Center 
(PTTC) Network  
The purpose of the SAMHSA-funded PTTC Network 
is to improve implementation and delivery of 
effective substance misuse prevention interventions 
and provide training and technical assistance services 
to the substance misuse prevention field. The PTTC 
Network develops and disseminates tools needed to 
improve the quality of substance misuse prevention 
efforts. The network also makes technical assistance, 
epidemiological data, and implementation resources 
available. https://pttcnetwork.org
 ■ Selecting Best-Fit Programs and 
Practices: Guidance for Substance 
Misuse Prevention Practitioners 
This resource places the selection of programs 
and practices within the broader context of 
evidence-based prevention by exploring the value 
of embedding program and practice selection in a 
strategic planning process. The guidance document 
provides information about how to identify and 
choose among appropriate programs and practices. 
Also included are tips for adopting, adapting, and 
innovating programs and practices at the local level.  
https://www.samhsa.gov/sites/default/files/ebp_
prevention_guidance_document_241.pdf
 ■ Toking, Smoking, and Public Health: 
Lessons from Tobacco Control for 
Marijuana Regulation  
This tool is a synopsis of regulatory public health 
issues related to marijuana legalization that are 
comparable to those faced in tobacco control. The 
synopsis also provides an overview of options 
that local and state governments might consider 
when developing marijuana regulations. https://
publichealthlawcenter.org/sites/default/files/
resources/Toking-Smoking-Public-Health-2018.pdf
 ■ Know the Risks of Marijuana
SAMHSA’s site dedicated to increasing understanding 
of marijuana provides public awareness messages, 
including ones oriented specifically to pregnancy. All 
of the messages can be downloaded and used at no 
cost. https://www.samhsa.gov/marijuana
Quality Improvement
Quality improvement involves systematic and 
continuous actions that lead to the measurable review 
of program outcomes and ongoing improvement 
activities in healthcare services. A continuous 
quality improvement process is directly linked to an 
organization’s commitment to measuring the impacts 
of service delivery and the underlying process and 
systems of delivering this care. 
Quality improvement can serve as a framework for 
improving the way prevention efforts are delivered. Most 
quality improvement models are based on an interactive 
process that continually builds on the experience and 
lessons learned as a prevention program is implemented. 
 ■ Developing and Sustaining Perinatal 
Quality Collaboratives : A Resource Guide 
for States  
Perinatal Quality Collaboratives (PQCs) are federally 
supported state or multi-state networks of perinatal 
care providers and public health professionals who 
work to improve health outcomes for women and 
newborns through continuous quality improvement. 
This resource guide provides information about 
starting statewide collaboratives, launching initiatives, 
using data and measurement, fostering sustainability, 
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and more. The guide also includes links to other 
useful resources for perinatal quality improvement 
work. https://www.cdc.gov/reproductivehealth/
maternalinfanthealth/pdf/Best-Practices-for-
Developing-and-Sustaining-Perinatal-Quality-
Collaboratives_tagged508.pdf
 ■ Plan-Do-Study-Act (PDSA)   
The PDSA cycle is part of the Institute for 
Healthcare Improvement Model for Improvement, 
a tool for accelerating quality improvement. The 
PDSA cycle is the scientific method used for action-
oriented learning, and involves testing a change 
by planning it, trying it, observing the results, and 
acting on what is learned. https://innovations.ahrq.
gov/qualitytools/plan-do-study-act-pd 
sa-cycle
Evaluation
The purpose of program evaluation is to monitor a 
program’s impact and outcomes. Key components 
involve selecting program goals, establishing data 
outcomes to measure, determining the intended 
outcomes, and selecting the indicators that support 
those outcomes. 
It is also important to determine which tools provide 
the best measurement of intended outcomes. 
Examining variations in a program’s service 
components and delivery processes informs how 
outcomes are achieved, and how these impact specific 
populations. 
Effective program evaluation can also inform policy 
development and change. Examples of program 
evaluation include:
 ■ Monitoring the consistency with which programs 
and services are delivered and their adherence to 
established practice guidelines
 ■ Measuring and tracking client outcomes  
over time
 ■ Examining variations in outcomes for specific 
groups of clients
 ■ CDC Evaluation Resources 
This federal website offers links to resources on 
understanding, developing, and using logic models 
to support the strategic planning and evaluation of 
health-related initiatives. https://www.cdc.gov/eval/
resources/index.htm
 ■ A Framework for Program Evaluation 
This framework guides public health professionals 
in their use of program evaluation, encouraging an 
approach to evaluation that is integrated with routine 
program operations. https://www.cdc.gov/eval/
framework/index.htm
 ■ Getting To Outcomes®: Improving 
Community-Based Prevention  
This federally supported toolkit is organized 
around a 10-step process to help communities plan, 
implement, and evaluate the impact of programs that 
seek to prevent negative behaviors among youth. 
https://www.rand.org/health-care/projects/getting-
to-outcomes.html
 ■ Policy Evaluation  
The CDC’s National Center for Injury Prevention 
and Control developed this series of briefs to 
increase the use of policy evaluation methods in the 
field of injury prevention and control. https://www.
cdc.gov/injury/about/evaluation.html
 ■ RE-AIM (Reach, Effectiveness, Adoption, 
Implementation, Maintenance)  
The goal of RE-AIM is to encourage program 
planners, evaluators, readers of journal articles, 
funders, and policy makers to pay more attention 
to essential program elements, including external 
validity that can improve the sustainable adoption 
and implementation of effective, generalizable, 
and evidence-based interventions. 
http://www.re-aim.org
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